209 related articles for article (PubMed ID: 20425379)
1. Richter's transformation in chronic lymphocytic leukemia.
Tsimberidou AM; Keating MJ; Wierda WG
Curr Hematol Malig Rep; 2007 Oct; 2(4):265-71. PubMed ID: 20425379
[TBL] [Abstract][Full Text] [Related]
2. Richter's transformation in chronic lymphocytic leukemia.
Tsimberidou AM; Keating MJ
Semin Oncol; 2006 Apr; 33(2):250-6. PubMed ID: 16616072
[TBL] [Abstract][Full Text] [Related]
3. Richter syndrome: biology, incidence, and therapeutic strategies.
Tsimberidou AM; Keating MJ
Cancer; 2005 Jan; 103(2):216-28. PubMed ID: 15578683
[TBL] [Abstract][Full Text] [Related]
4. Clinical outcomes and prognostic factors in patients with Richter's syndrome treated with chemotherapy or chemoimmunotherapy with or without stem-cell transplantation.
Tsimberidou AM; O'Brien S; Khouri I; Giles FJ; Kantarjian HM; Champlin R; Wen S; Do KA; Smith SC; Lerner S; Freireich EJ; Keating MJ
J Clin Oncol; 2006 May; 24(15):2343-51. PubMed ID: 16710033
[TBL] [Abstract][Full Text] [Related]
5. Richter's transformation in chronic lymphocytic leukemia.
Jain P; O'Brien S
Oncology (Williston Park); 2012 Dec; 26(12):1146-52. PubMed ID: 23413591
[TBL] [Abstract][Full Text] [Related]
6. Safety and activity of the anti-CD79B antibody-drug conjugate polatuzumab vedotin in relapsed or refractory B-cell non-Hodgkin lymphoma and chronic lymphocytic leukaemia: a phase 1 study.
Palanca-Wessels MC; Czuczman M; Salles G; Assouline S; Sehn LH; Flinn I; Patel MR; Sangha R; Hagenbeek A; Advani R; Tilly H; Casasnovas O; Press OW; Yalamanchili S; Kahn R; Dere RC; Lu D; Jones S; Jones C; Chu YW; Morschhauser F
Lancet Oncol; 2015 Jun; 16(6):704-15. PubMed ID: 25925619
[TBL] [Abstract][Full Text] [Related]
7. Richter's transformation of chronic lymphocytic leukemia with Hodgkin's-like cells is associated with Epstein-Barr virus infection.
Rubin D; Hudnall SD; Aisenberg A; Jacobson JO; Harris NL
Mod Pathol; 1994 Jan; 7(1):91-8. PubMed ID: 8159658
[TBL] [Abstract][Full Text] [Related]
8. EBV negative Richter's syndrome from a coexistent clone after salvage treatment with alemtuzumab in a CLL patient.
Janssens A; Berth M; De Paepe P; Verhasselt B; Van Roy N; Noens L; Philippé J; Offner F
Am J Hematol; 2006 Sep; 81(9):706-12. PubMed ID: 16838338
[TBL] [Abstract][Full Text] [Related]
9. Richter syndrome: A rare complication of chronic lymphocytic leukemia or small lymphocytic lymphoma.
Wąsik-Szczepanek E; Szymczyk A; Szczepanek D; Wszoła-Kleinrok J; Chocholska S; Pluta A; Hus M
Adv Clin Exp Med; 2018 Dec; 27(12):1683-1689. PubMed ID: 30156387
[TBL] [Abstract][Full Text] [Related]
10. Richter's transformation to diffuse large B-cell lymphoma: a retrospective study reporting clinical data, outcome, and the benefit of adding rituximab to chemotherapy, from the Israeli CLL Study Group.
Tadmor T; Shvidel L; Bairey O; Goldschmidt N; Ruchlemer R; Fineman R; Rahimi-Levene N; Herishanu Y; Yuklea M; Arad A; Aviv A; Polliack A;
Am J Hematol; 2014 Nov; 89(11):E218-22. PubMed ID: 25110869
[TBL] [Abstract][Full Text] [Related]
11. Richter syndrome: a review of clinical, ocular, neurological and other manifestations.
Omoti CE; Omoti AE
Br J Haematol; 2008 Sep; 142(5):709-16. PubMed ID: 18492119
[TBL] [Abstract][Full Text] [Related]
12. Epstein-Barr virus infection in Richter's transformation.
Ansell SM; Li CY; Lloyd RV; Phyliky RL
Am J Hematol; 1999 Feb; 60(2):99-104. PubMed ID: 9929100
[TBL] [Abstract][Full Text] [Related]
13. Cutaneous Richter's syndrome, prognosis, and clinical, histological and immunohistological patterns: report of four cases and review of the literature.
Duong T; Grange F; Auffret N; Aractingi S; Bodemer C; Brousse N; Hermine O; Fraitag S
Dermatology; 2010; 220(3):226-33. PubMed ID: 20145381
[TBL] [Abstract][Full Text] [Related]
14. Phase I-II study of oxaliplatin, fludarabine, cytarabine, and rituximab combination therapy in patients with Richter's syndrome or fludarabine-refractory chronic lymphocytic leukemia.
Tsimberidou AM; Wierda WG; Plunkett W; Kurzrock R; O'Brien S; Wen S; Ferrajoli A; Ravandi-Kashani F; Garcia-Manero G; Estrov Z; Kipps TJ; Brown JR; Fiorentino A; Lerner S; Kantarjian HM; Keating MJ
J Clin Oncol; 2008 Jan; 26(2):196-203. PubMed ID: 18182662
[TBL] [Abstract][Full Text] [Related]
15. Hodgkin's disease variant of Richter's syndrome clonally related to chronic lymphocytic leukemia arises in ZAP-70 negative mutated CLL.
Tzankov A; Fong D
Med Hypotheses; 2006; 66(3):577-9. PubMed ID: 16223567
[TBL] [Abstract][Full Text] [Related]
16. The role of rituximab in autologous and allogeneic hematopoietic stem cell transplantation for non-Hodgkin's lymphoma.
Naparstek E
Curr Hematol Malig Rep; 2006 Dec; 1(4):220-9. PubMed ID: 20425317
[TBL] [Abstract][Full Text] [Related]
17. Coexistence of chronic myeloid leukemia and diffuse large B-cell lymphoma with antecedent chronic lymphocytic leukemia: a case report and review of the literature.
Abuelgasim KA; Rehan H; Alsubaie M; Al Atwi N; Al Balwi M; Alshieban S; Almughairi A
J Med Case Rep; 2018 Mar; 12(1):64. PubMed ID: 29524963
[TBL] [Abstract][Full Text] [Related]
18. De novo CD5-positive and Richter's syndrome-associated diffuse large B cell lymphomas are genotypically distinct.
Matolcsy A; Chadburn A; Knowles DM
Am J Pathol; 1995 Jul; 147(1):207-16. PubMed ID: 7541611
[TBL] [Abstract][Full Text] [Related]
19. Rituximab: a review of its use in non-Hodgkin's lymphoma and chronic lymphocytic leukaemia.
Cvetković RS; Perry CM
Drugs; 2006; 66(6):791-820. PubMed ID: 16706552
[TBL] [Abstract][Full Text] [Related]
20. Spotlight on rituximab in non-Hodgkin lymphoma and chronic lymphocytic leukemia.
Cvetković RS; Perry CM
BioDrugs; 2006; 20(4):253-7. PubMed ID: 16831024
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
